Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
6.89
+0.03 (0.44%)
At close: Jan 17, 2025, 4:00 PM
6.87
-0.02 (-0.29%)
After-hours: Jan 17, 2025, 5:32 PM EST
Accolade Employees
Accolade had 2,400 employees as of February 29, 2024. The number of employees increased by 30 or 1.27% compared to the previous year.
Employees
2,400
Change (1Y)
30
Growth (1Y)
1.27%
Revenue / Employee
$186,133
Profits / Employee
-$75,124
Market Cap
562.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ACCD News
- 10 days ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Accolade - PRNewsWire
- 12 days ago - ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD - Business Wire
- 12 days ago - Why Is Accolade Stock Trading Over 100% On Tuesday? - Benzinga
- 12 days ago - Healthcare M&A: Transcarent paying $621M to acquire Seattle-based health benefits firm Accolade - GeekWire
- 12 days ago - Transcarent To Acquire Accolade - Business Wire
- 5 weeks ago - Accolade to Announce Fiscal Third Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Accolade: A GARP Stock Trading Well Under 1X Revenues - Seeking Alpha
- 2 months ago - Accolade To Present at Upcoming Investor Conferences - GlobeNewsWire